CureVac N.V. (CVAC) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2025
Loading P/E history...
CVAC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, CureVac N.V. (CVAC) trades at a price-to-earnings ratio of 6.5x, with a stock price of $4.66 and trailing twelve-month earnings per share of $0.86.
The current P/E is 28% above its 5-year average of 5.1x. Over the past five years, CVAC's P/E has ranged from a low of 3.4x to a high of 6.2x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, CVAC trades at a 71% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, CVAC trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CVAC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CVAC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $39B | 127.0 | -Best | +207%Best | |
| $151B | 19.5Lowest | -Best | -4% | |
| $536B | 38.4 | -Best | -58% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
CVAC Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $5.43 | $0.87 | 6.2x | +24% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $2.77 | $0.81 | 3.4x | -32% |
| FY2024 Q4 | $3.41 | $0.73 | 4.7x | -8% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $2.94 | $0.50 | 5.9x | +16% |
Average P/E for displayed period: 5.1x
See CVAC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CVAC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CVAC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCVAC — Frequently Asked Questions
Quick answers to the most common questions about buying CVAC stock.
Is CVAC stock overvalued or undervalued?
CVAC trades at 6.5x P/E, above its 5-year average of 5.1x. The 100th percentile ranking indicates a premium to historical valuation.
How does CVAC's valuation compare to peers?
CureVac N.V. P/E of 6.5x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is CVAC's PEG ratio?
CVAC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2025.